Searched over 200M research papers
6 papers analyzed
Some studies suggest quinapril is more effective in certain populations, while other studies suggest lisinopril is more effective or both drugs are similarly effective in lowering blood pressure with similar tolerance and adverse effects.
20 papers analyzed
Quinapril and lisinopril are both angiotensin-converting enzyme (ACE) inhibitors used to manage mild to moderate arterial hypertension. Understanding their comparative efficacy and safety is crucial for optimizing patient outcomes.
Studies have shown that both quinapril and lisinopril effectively reduce systolic and diastolic blood pressure. In one study, systolic blood pressure decreased significantly from 172.6 to 152.6 mmHg in the lisinopril group and from 171.6 to 147 mmHg in the quinapril group . Diastolic blood pressure also saw significant reductions, from 105.6 to 86.8 mmHg with lisinopril and from 106.1 to 88.1 mmHg with quinapril .
Using ABPM, lisinopril showed a more significant reduction in mean systolic blood pressure (from 157.3 to 126.5 mmHg) compared to quinapril (from 148 to 137.4 mmHg) . Similarly, mean diastolic blood pressure decreased more with lisinopril (from 93.6 to 81.7 mmHg) than with quinapril (from 89.4 to 85.9 mmHg) .
In elderly patients with low blood renin levels, both drugs were effective and well-tolerated. However, quinapril provided a more effective and consistent control of hypertension over a 24-hour period.
Lisinopril normalized blood pressure in 83% of patients, compared to 45% for quinapril after 4 and 8 weeks of treatment. This suggests that lisinopril may be more effective in achieving target blood pressure levels in a shorter time frame.
Quinapril was associated with a significant reduction in heart rate from week 8 onwards, while lisinopril did not affect heart rate. Both drugs caused a significant increase in serum potassium levels, but other biochemical parameters remained stable.
A study evaluating therapeutic interchange programs found that dosing ratios for converting patients from lisinopril and quinapril to benazepril were accurate 83% and 78% of the time, respectively. This indicates a high level of consistency in dosing guidelines for these ACE inhibitors.
Both quinapril and lisinopril are effective in reducing blood pressure in patients with mild to moderate hypertension. Lisinopril appears to offer a more significant reduction in both systolic and diastolic blood pressure, as well as higher normalization rates. Quinapril, however, may provide more consistent 24-hour blood pressure control, particularly in elderly patients. When considering therapeutic interchange, dosing guidelines for these medications are generally reliable.
Most relevant research papers on this topic